[ASAP] Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody–Drug Conjugate Payloads

AI Summary

This title suggests that the research focuses on designing and optimizing a type of drug called Toll-like receptor 7/8 agonists to be used as payloads for antibody-drug conjugates. The aim is to create drugs that can be targeted to specific cells, making them more effective and reducing side effects. This research is significant in the field of drug development as it has the potential to lead to the creation of new and more efficient treatments for a variety of diseases.

Leave a Reply